胃滞留缓释片的研究进展
作者：赵强;陈建明;
Author：
收稿日期： 年卷（期）页码：2012,27(06):-718-721
期刊名称：华西药学杂志
Journal Name：WEST CHINA JOURNAL OF PHARMACEUTICAL SCIENCES
关键字：胃滞留缓释片;胃内漂浮;生物利用度;体内外评价
Key words：
基金项目：
中文摘要
简单介绍胃滞留缓释片的特点及适于该剂型的药物,同时结合近些年国内外相关文献,对其给药原理、类型、体内外评价标准及发展状况进行综述。
参考文献
[1]Prajapati ST,Patel LD,Patel DM,et al.Gastric floating matrixtablets:Design and optimization using combination of polymers[J].Acta Pharm,2008,58(2):221-229.
[2]Singh BN,Kim KH.Floating drug delivery systems:An approachto oral controlled drug delivery via gastric retention[J].J ControlRelease,2000,63(3):235-259.
[3]Mostafavi A,Emami J,Varshosaz J,et al.Development of a pro-longed-release gastroretentive tablet formulation of ciprofloxacinhydrochloride:Pharmacokinetic characterization in healthy humanvolunteers[J].Int J Pharm,2011,409(1-2):128-136.
[4]Baumgartner S,Kristl J,Vrecer F,et al.Optimisation of floatingmatrix tablets and evaluation of their gastric residence time[J].Int J Pharm,2000,195(1-2):125-135.
[5]段尧,易宜昌,聂中越.硫酸庆大霉素缓释片的制备及其体外释放度的试验研究[J].中国现代应用药学杂志,2006,23(7):635-636.
[6]季冬英,吴琼珠.复方替加氟胃滞留型缓释片的处方研究[J].中国药科大学学报,2007,38(3):221-224.
[7]Urquhart J,Theeuwes F.Drug delivery system comprising a reser-voir containing a plurality of tiny pills[P].US 4434153.1984-02-28.
[8]Chen J,Park K.Synthesis and characterization of superporous hydro-gel composites[J].J Control Release,2000,65(1-2):73-82.
[9]Chen J,Blevins WE,Park H,et al.Gastric retention properties ofsuperporous hydrogel composites[J].J Control Release,2000,64(1-3):39-51.
[10]Klausner EA,Lavy E,Friedman M,et al.Expandable gastro-retentive dosage forms[J].J Control Release,2003,90(2):143-162.
[11]Islam MS,Azam KR,Chowdhury JA,et al.Comparison of gastroretention time and in vitro release profile studies of ciprofloxacinHCL from co-martix tablets of hydrophilic polymers[J].DhakaUniv J Pharm Sci,2009,8(1):67-73.
[12]Chavanpatil MD,Jain P,Chaudhari S,et al.Novel sustained re-lease,swellable and bioadhesive gastroretentive drug delivery sys-tem for ofloxacin[J].Int J Pharm,2006,316(1-2):86-92.
[13]Guan J,Zhou L,Nie S,et al.A novel gastric-resident osmoticpump tablet:in vitro and in vivo evaluation[J].Int J Pharm,2010,383(1-2):30-36.
[14]Patel A,Modasiya M,Shah D,et al.Development and in vivofloating behavior of verapamil HCl intragastric floating tablets[J].AAPS Pharm Sci Tech,2009,10(1):310-315.
[15]Wei Z,Yu Z,Bi D.Design and evalution of a two-layer floatingtablet for gastric retention using cisapride as a model drug[J].Drug Dev Ind Pharm,2001,27(5):469-474.
[16]张朔,姜典卓,邹宇清,等.VBl胃内滞留型漂浮缓释片释放度及漂浮性能的研究[J].沈阳药科大学学报,2002,19(4):253-259.
[17]Bani-Jaber A,Al-Aani L,Alkhatib H,et al.Prolonged intra-gastric drug delivery mediated by EudragitE-carrageenanpolyelectrolyte matrix tablets[J].AAPS Pharm Sci Tech,2011,12(1):354-361.
[18]刘卫卫,蒋雪涛,王建文,等.胃黏附片及黏附辅料的体外评价[J].中国医药工业杂志,2000,31(7):302-304.
[19]Narendra C,Srinath MS,Babu G.Optimization of bilayer floatingtablet containing metoprolol tartrate as a model drug for gastric re-tention[J].AAPS Pharm Sci Tech,2006,7(2):E1-E7.
[20]刘丽平,孙淑英,等.桂利嗪胃内滞留漂浮型缓释片的制备[J].中国新药杂志,2010,19(7):632-637.
[21]Hwang SJ,Park H,Park K.Gastric retentive drug-delivery sys-tems[J].Crit Rev Ther Drug Carrier Syst,1998,15(3):243-284.
[22]Fabbrini G,Stasio FD,BLOISE M,et al.Soluble and controlled-release preparations of levodopa:Do we really need them[J].JNeurol,2010,257(12):292-297.
[23]Nakano E,Mushtaq S,Heath PR,et al.Riboflavin depletion im-pairs cell proliferation in adult human duodenum:Identification ofpotential effector[J].Dig Dis Sci,2011,56(4):1007-1019.
[24]Klausner EA,Lavy E,Stepensky D,et al.Furosemide pharmaco-kinetics and pharmacodynamics following gastroretentive dosageform administration to healthy volunteers[J].J Clin Pharmacol,2003,43(7):711-720.
[25]Klausner EA,Lavy E,Stepensky D,et al.Novel gastroretentivedosage forms:Evaluation of gastroretentivity and its effect on ribo-favin absorption in dogs[J].Pharm Res,2002,19(10):1516-1523.
[26]Curatolo WJ,Lo J.Gastric retention system for controlled drug re-lease[P].US 5443843.1995-08-22.
[27]Antila S,Huuskonen H,Nevalainen T,et al.Site dependent bio-availability and metabolism of levosimendan in dogs[J].Eur JPharm Sci,1999,9(1):85-91.
[28]Whitehead L,Fell JT,Collett JH,et al.Floating dosage forms:Anin vivo study demonstrating prolonged gastric retention[J].J Con-trol Release,1998,55(1):3-12.
[29]Steingoetter A,Weishaupt D,Kunz P,et al.Magnetic resonanceimaging for the in vivo evaluation of gastric-retentive tablets[J].Pharm Res,2003,20(12):2001-2007.
【关闭】
